Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer
 

http://abstract.asco.org/AbstView_102_83401.html

Hopeful

Re: Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer
 

This is a great post. I received 9 week Herceptin and Taxotere and was Stage IIIB four years ago. So far, there is no evidence of disease and I'm in good condition. No doubt, this was the best treatment to me.

Re: Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer
 

Ursula,

I am so happy to hear you are doing well. Thanks for sharing your experience; I know many patients grow anxious when they have to stop Herceptin before their one year is up due to heart problems. Your post is a boost to all of them.

Regards,

Hopeful